GB202102606D0 - Treatment of ovarian cancer minimal residual disease - Google Patents
Treatment of ovarian cancer minimal residual diseaseInfo
- Publication number
- GB202102606D0 GB202102606D0 GBGB2102606.7A GB202102606A GB202102606D0 GB 202102606 D0 GB202102606 D0 GB 202102606D0 GB 202102606 A GB202102606 A GB 202102606A GB 202102606 D0 GB202102606 D0 GB 202102606D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- ovarian cancer
- residual disease
- minimal residual
- minimal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010033128 Ovarian cancer Diseases 0.000 title 1
- 206010061535 Ovarian neoplasm Diseases 0.000 title 1
- 208000007660 Residual Neoplasm Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/54—Determining the risk of relapse
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2102606.7A GB202102606D0 (en) | 2021-02-24 | 2021-02-24 | Treatment of ovarian cancer minimal residual disease |
| PCT/GB2022/050497 WO2022180393A2 (en) | 2021-02-24 | 2022-02-23 | Treatment of ovarian cancer minimal residual disease |
| GB2314598.0A GB2619478A (en) | 2021-02-24 | 2022-02-23 | Treatment of ovarian cancer minimal residual disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2102606.7A GB202102606D0 (en) | 2021-02-24 | 2021-02-24 | Treatment of ovarian cancer minimal residual disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202102606D0 true GB202102606D0 (en) | 2021-04-07 |
Family
ID=75339170
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2102606.7A Ceased GB202102606D0 (en) | 2021-02-24 | 2021-02-24 | Treatment of ovarian cancer minimal residual disease |
| GB2314598.0A Pending GB2619478A (en) | 2021-02-24 | 2022-02-23 | Treatment of ovarian cancer minimal residual disease |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2314598.0A Pending GB2619478A (en) | 2021-02-24 | 2022-02-23 | Treatment of ovarian cancer minimal residual disease |
Country Status (2)
| Country | Link |
|---|---|
| GB (2) | GB202102606D0 (en) |
| WO (1) | WO2022180393A2 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1293205A1 (en) * | 2001-09-18 | 2003-03-19 | G2M Cancer Drugs AG | Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease |
| US20190142835A1 (en) * | 2017-11-14 | 2019-05-16 | Oregon Health & Science University | Inhibition of autophagy using phospholipase a2 inhibitors |
| CN112771214A (en) * | 2018-09-27 | 2021-05-07 | 瓦西博迪公司 | Methods for selecting neoepitopes |
| GB201902653D0 (en) * | 2019-02-27 | 2019-04-10 | Univ Oxford Innovation Ltd | High-grade serous ovarian carcinoma (HGSOC) |
-
2021
- 2021-02-24 GB GBGB2102606.7A patent/GB202102606D0/en not_active Ceased
-
2022
- 2022-02-23 GB GB2314598.0A patent/GB2619478A/en active Pending
- 2022-02-23 WO PCT/GB2022/050497 patent/WO2022180393A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022180393A3 (en) | 2022-10-13 |
| WO2022180393A2 (en) | 2022-09-01 |
| GB202314598D0 (en) | 2023-11-08 |
| GB2619478A (en) | 2023-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202104923YA (en) | Pharmaceutical combination for treatment of cancer | |
| SG11202011117VA (en) | Treatment of cancer | |
| EP4010081A4 (en) | Combination therapy for treatment of cancer | |
| EP4125846A4 (en) | Pyrazolylpropanamide compounds and uses thereof for treatment of prostate cancer | |
| GB201919428D0 (en) | Immunotherapeutic treatment of cancer | |
| SG11202107017TA (en) | Methods of treating cancer | |
| IL283742A (en) | Novel approach for treatment of cancer using immunomodulation | |
| EP4087661A4 (en) | Lasso peptides for treatment of cancer | |
| EP4037761C0 (en) | Device for radiotherapy treatment of cancer patients | |
| GB202314598D0 (en) | Treatment of ovarian cancer minimal residual disease | |
| IL289201A (en) | Compounds for treatment of cancer | |
| IL291626A (en) | Treatment of celiac disease | |
| GB202102257D0 (en) | Treatment of shells | |
| GB202018015D0 (en) | Composition and methods for the treatment of intestinal cancer | |
| GB202107994D0 (en) | Treatment of cancer | |
| GB202018062D0 (en) | Treatment of cancer | |
| GB202008037D0 (en) | Treatment of cancer | |
| GB202311976D0 (en) | Treatment of cancer | |
| GB202218181D0 (en) | Treatment of cancer | |
| GB202201803D0 (en) | Treatment of Cancer | |
| GB202004514D0 (en) | Treatment of Immunosuppressive Cancer | |
| IL300106A (en) | Combination therapy for treatment of cancer | |
| GB201918815D0 (en) | Treatment of cancer | |
| IL272390A (en) | Methods of treating cancer | |
| IL305780A (en) | Methods for the treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |